Literature DB >> 20586874

Assessment of in vitro biofilm formation by Helicobacter pylori.

Hideo Yonezawa1, Takako Osaki, Satoshi Kurata, Cynthia Zaman, Tomoko Hanawa, Shigeru Kamiya.   

Abstract

BACKGROUND AND AIMS: Biofilms are surface-bound communities of bacterial cells that are implicated in their survival. As with various bacteria studied to date, Helicobacter pylori can have an alternate lifestyle as a biofilm. We previously reported that strain TK1402 showed a strong biofilm-forming ability in vitro. However, the mechanisms of its biofilm development remain unclear. We analyzed the basic characteristics of the biofilm-forming ability in strain TK1402.
METHODS: In order to characterize the biofilm-forming ability of the H. pylori strains, auto-aggregation, motility and hydrophobicity, which are important factors in biofilm formation by other bacteria, were analyzed. Further, we tested whether cell growth participated in biofilm formation in strain TK1402.
RESULTS: There were no significant differences in the auto-aggregation, motility and hydrophobicity of strain TK1402 compared with the other strains. On the other hand, pre-culture of this strain for 24-48 h resulted in decreased biofilm formation.
CONCLUSION: TK1402 is a strong biofilm-forming strain of H. pylori in Brucella broth supplemented with 7% fetal calf serum. It is possible that biofilm-forming cell growth is a principal factor in biofilm development.

Entities:  

Mesh:

Year:  2010        PMID: 20586874     DOI: 10.1111/j.1440-1746.2009.06213.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  27 in total

1.  Characterization of Key Helicobacter pylori Regulators Identifies a Role for ArsRS in Biofilm Formation.

Authors:  Stephanie L Servetas; Beth M Carpenter; Kathryn P Haley; Jeremy J Gilbreath; Jennifer A Gaddy; D Scott Merrell
Journal:  J Bacteriol       Date:  2016-08-25       Impact factor: 3.490

2.  Functional analysis of ycfR and ycfQ in Escherichia coli O157:H7 linked to outbreaks of illness associated with fresh produce.

Authors:  Kaiping Deng; Siyun Wang; Xiaoqian Rui; Wei Zhang; Mary Lou Tortorello
Journal:  Appl Environ Microbiol       Date:  2011-04-15       Impact factor: 4.792

3.  N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.

Authors:  Luís Eduardo S Fontes; Ana Luiza C Martimbianco; Carolina Zanin; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2019-02-12

Review 4.  Microbial biofilms and gastrointestinal diseases.

Authors:  Erik C von Rosenvinge; Graeme A O'May; Sandra Macfarlane; George T Macfarlane; Mark E Shirtliff
Journal:  Pathog Dis       Date:  2013-01-29       Impact factor: 3.166

5.  The potential role of N-acetylcysteine for the treatment of Helicobacter pylori.

Authors:  Kian Makipour; Frank K Friedenberg
Journal:  J Clin Gastroenterol       Date:  2011 Nov-Dec       Impact factor: 3.062

6.  Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori In Vitro and In Vivo.

Authors:  Peipei Luo; Yanqiang Huang; Xudong Hang; Qian Tong; Liping Zeng; Jia Jia; Guoxin Zhang; Hongkai Bi
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

Review 7.  Biofilms and Helicobacter pylori: Dissemination and persistence within the environment and host.

Authors:  Steven L Percival; Louise Suleman
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 8.  Biofilm and Helicobacter pylori: from environment to human host.

Authors:  Apolinaria García; María José Salas-Jara; Carolina Herrera; Carlos González
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 9.  Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis.

Authors:  Skander Hathroubi; Stephanie L Servetas; Ian Windham; D Scott Merrell; Karen M Ottemann
Journal:  Microbiol Mol Biol Rev       Date:  2018-05-09       Impact factor: 11.056

Review 10.  Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.

Authors:  Evariste Tshibangu-Kabamba; Yoshio Yamaoka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-17       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.